Patent-pending Coretrak is designed for challenging fixation cases of the foot, such as those involving diabetic patients.
As a minimally invasive solution, Wright Medical Group says Coretrak can aid healing, which is important for the growing population of diabetics who are already at a high risk for surgical complications, the company stated.
Read Wright Medical Group’s release about the Coretrak.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
